CN Stock MarketDetailed Quotes

002370 Zhejiang Yatai Pharmaceutical

Watchlist
  • 3.33
  • +0.05+1.52%
Not Open Apr 24 15:00 CST
2.48BMarket Cap72.39P/E (TTM)

About Zhejiang Yatai Pharmaceutical Company

The company, formerly known as Zhejiang Asia Pacific Pharmaceutical Factory, was founded in 1989 and is now located at No. 36 Nanbin West Road, Lihai Street, Yuecheng District, Shaoxing City, Zhejiang Province. The shareholding system reform was completed in December 2001, and officially listed on the Shenzhen Stock Exchange on March 16, 2010. Currently, the company's products cover several major sectors such as chemical preparations, chemical raw materials, and drug research and development. Ningbo Fubon Holding Group is a large private group integrating commerce, real estate, energy, sports and other industries, and has been listed as a top 500 enterprise over the years. On April 15, 2022, Fubon Group joined Asia Pacific Pharmaceutical as the controlling shareholder, and Asia Pacific Pharmaceutical became a member of the big health industry chain under Fubon Group. The company's main business is pharmaceutical manufacturing, including R&D, production and sales of chemical agents. The main customers are pharmaceutical businesses, distribution companies and medical institutions. The company's main products are antibiotics, antiviral, cardiovascular, digestive, antipyretic and analgesic chemicals. Corporate honors: Enterprise Credit Rating AAA; Shaoxing County Advanced Tax Payment Unit; Shaoxing County Advanced Tax Payment Unit; Shaoxing County Family Planning Advanced Unit; Shaoxing County Enterprise Credit Rating AAA, etc.

Company Profile

Short Name-A亚太药业
Symbol-A002370
Company NameZhejiang Yatai Pharmaceutical Co.,Ltd.
Listing DateMar 16, 2010
Issue Price16.00
Shares Offered30.00M share(s)
FoundedDec 31, 2001
Listed ExchangeSZ Stock Exchange
Legal Representativejianwei cen
General Managerjianwei cen
Secretarywei xu
Accounting FirmZTE Caiguanghua Certified Public Accountants (Special General) (Partnership)
Securities Representativefeng zhu
Legal CounselBeijing Guofeng (Hangzhou) Law Firm
Employees529
Phone0575-84810101
Office AddressNo. 36 Nanbin West Road, Lihai Town, Binhai New Town, Shaoxing, Zhejiang
Zip Code312366
Registered AddressRoom 1501, 2003 Qunxian Road, Keqiao District, Shaoxing City, Zhejiang Province
Fax0575-84810101
Emailytdsh@ytyaoye.com
Business License330000000006107
BusinessLicense items: pharmaceutical production; pharmaceutical production (application of preparation techniques such as steaming, frying, and calcination of traditional Chinese medicine tablets and production of confidential prescription products for proprietary Chinese medicines); contract production of pharmaceuticals; import and export of pharmaceuticals; drug internet information services (for projects subject to approval according to law, business activities can only be carried out after approval by relevant departments; specific business projects are subject to approval). General projects: manufacture of basic chemical raw materials (manufacture of licensed chemicals excluding hazardous chemicals, etc.); medical research and experimental development; medical research and experimental development (except for human stem cells, genetic diagnosis and treatment technology development and development); technical services, technology development, technical consultation, technology exchange, technology transfer, technology promotion; investment management (with the exception of projects subject to approval by law, independently carry out business activities with a business license in accordance with law).

Company Executives

  • Name
  • Position
  • Salary
  • lingjie song
  • Chairman, Directors, Strategic Decision Committee Convener
  • --
  • lingbo song
  • Directors, Audit Committee Member
  • --
  • jianwei cen
  • Directors, General Manager, Member of the Remuneration and Assessment Committee, Member of the Strategic Decision Committee
  • 570.60K
  • wei xu
  • Directors, Board Secretary
  • 493.70K
  • wei huang
  • Directors
  • 448.40K
  • xiaoming huang
  • Directors, Member of the Strategic Decision Committee, Nomination Committee Members
  • 31.80K
  • yuehui liu
  • Independent Directors, Audit Committee Member, Nomination Committee Convener, Member of the Strategic Decision Committee
  • 100.00K
  • haizhou lv
  • Independent Directors, Remuneration and Assessment Committee Convener, Nomination Committee Members, Member of the Strategic Decision Committee, Audit Committee Convener
  • 100.00K
  • min cai
  • Independent Directors, Member of the Remuneration and Assessment Committee
  • 100.00K
  • feng zhu
  • Securities Affairs Representative
  • --
  • guoqiang ye
  • Chairman of the Supervisory Board, Employee Supervisors
  • 373.20K
  • huaying zhou
  • Auditors
  • 176.90K
  • min tu
  • Auditors
  • --
  • qinshui tan
  • Deputy General Manager
  • 463.50K
  • jingyang xu
  • Chief Financial Officer
  • 484.20K
  • liqin tao
  • Head of Internal Audit
  • --

Market Insights

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More